Cargando…
Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms
Novel targeted therapeutics alone or in rational combinations are likely to dominate the future management of various hematological neoplasms. However, the challenges currently faced are the molecular heterogeneity in driver lesions and genetic plasticity leading to multiple resistance pathways. Thu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8885406/ https://www.ncbi.nlm.nih.gov/pubmed/35091658 http://dx.doi.org/10.1038/s41375-021-01483-z |